CWAG
TMO icon

Compton Wealth Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Compton Wealth Advisory Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$983K Buy
1,507
+113
+8% +$67.1K 0.2% 57
2026
Q2 		$716K Sell
1,394
-3
-0.2% -$1.44K 0.14% 64
2026
Q1 		$691K Sell
1,397
-552
-28% -$300K 0.15% 63
2025
Q4 		$1.13M Sell
1,949
-7
-0.4% -$3.96K 0.25% 55
2025
Q3 		$949K Buy
1,956
+192
+11% +$89.4K 0.22% 55
2025
Q2 		$715K Sell
1,764
-262
-13% -$110K 0.18% 57
2025
Q1 		$1.01M Sell
2,026
-112
-5% -$60.7K 0.28% 52
2024
Q4 		$1.11M Buy
2,138
+66
+3% +$36.3K 0.29% 54
2024
Q3 		$1.28M Buy
2,072
+28
+1% +$16.6K 0.32% 54
2024
Q2 		$1.13M Buy
2,044
+7
+0.3% +$4.01K 0.3% 54
2024
Q1 		$1.18M Buy
2,037
+22
+1% +$12.3K 0.32% 55
2023
Q4 		$1.07M Buy
2,015
+309
+18% +$150K 0.34% 51
2023
Q3 		$864K Hold
1,706
– – 0.3% 58
2023
Q2 		$890K Sell
1,706
-56
-3% -$30.2K 0.3% 57
2023
Q1 		$1.02M Sell
1,762
-11
-0.6% -$6.2K 0.35% 53
2022
Q4 		$976K Sell
1,773
-15
-0.8% -$7.95K 0.38% 53
2022
Q3 		$907K Sell
1,788
-7
-0.4% -$3.92K 0.39% 54
2022
Q2 		$975K Buy
1,795
+104
+6% +$57.2K 0.42% 53
2022
Q1 		$999K Buy
1,691
+120
+8% +$68.9K 0.39% 56
2021
Q4 		$1.05M Buy
1,571
+29
+2% +$18.1K 0.45% 52
2021
Q3 		$881K Sell
1,542
-28
-2% -$15.4K 0.41% 50
2021
Q2 		$792K Buy
1,570
+10
+0.6% +$4.72K 0.37% 51
2021
Q1 		$712K Buy
1,560
+708
+83% +$338K 0.41% 48
2020
Q4 		$397K Buy
+852
New +$399K 0.25% 63

Other funds holding TMO

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
James Hambro & Partners
James Hambro & Partners London, United Kingdom $2.87B AUM 19.92% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Guyasuta Investment Advisors
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.91B AUM 26.66% 1-Year Est. Return
Caledonia Investments plc (UK)
Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Compton Wealth Advisory Group's TMO Position: Q3 2026 in Review

Compton Wealth Advisory Group increased its Thermo Fisher Scientific (TMO) stake by 8.1% in Q3 2026, buying an estimated $67.1K and bringing the position to 1,507 shares worth $983K. The position accounts for 0.2% of the portfolio, ranked #57.

Compton Wealth Advisory Group first reported a position in TMO in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.28M in Q3 2024. 507 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Compton Wealth Advisory Group held 1,507 shares of Thermo Fisher Scientific worth $983K as of Q3 2026.
  • Compton Wealth Advisory Group bought 113 Thermo Fisher Scientific shares in Q3 2026, an estimated $67.1K.
  • Thermo Fisher Scientific made up 0.2% of Compton Wealth Advisory Group's portfolio in Q3 2026, its #57 holding.
  • Compton Wealth Advisory Group first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 24 quarters since.
  • Compton Wealth Advisory Group's Thermo Fisher Scientific position peaked at $1.28M in Q3 2024.
  • 507 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Compton Wealth Advisory Group's 13F filing for Q3 2026, filed 13 Oct 2026.